The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of distamab vedotin combined with carboplatin and bevacizumab for HER2-expressing platinum-sensitive ovarian cancer with prior PARPi treatment.
 
Huijuan Yang
No Relationships to Disclose
 
Wei Jiang
No Relationships to Disclose
 
Xuan Pei
No Relationships to Disclose
 
Yi Wang
No Relationships to Disclose
 
Shuai Liu
No Relationships to Disclose
 
Yi Fu
No Relationships to Disclose
 
Yufan Cheng
No Relationships to Disclose
 
Shaoxian Tang
No Relationships to Disclose